Showing 301 - 320 results of 11,927 for search '"Hepatocellular carcinoma"', query time: 0.20s Refine Results
  1. 301

    Progress in research, diagnosis, and treatment of hepatocellular carcinoma in 2022 by ZHAO Haichao, GAO Qiang

    Published 2023-04-01
    Subjects: “…|hepatocellular carcinoma|cancer screening|basic research|clinical research…”
    Get full text
    Article
  2. 302
  3. 303

    Improving clinical trial design for hepatocellular carcinoma treatments by Robert G. Gish, Garrett Hisatake

    Published 2011-12-01
    Subjects: “…Hepatocellular carcinoma - Clinical trials…”
    Get full text
    Article
  4. 304
  5. 305

    Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma by Song-Fong Huang, Sio-Wai Chong, Chun-Wei Huang, Heng-Yuan Hsu, Kuang-Tse Pan, Chien-Fu Hung, Tsung-Han Wu, Chao-Wei Lee, Chia-Hsun Hsieh, Ching-Ting Wang, Pei-Mei Chai, Ming-Chin Yu

    Published 2022-09-01
    “…Sorafenib has been used to treat advanced hepatocellular carcinoma (aHCC). However, there is no evidence for a response of different target lesions to sorafenib administration. …”
    Get full text
    Article
  6. 306

    Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma by Jaafar Khaled, Maria Kopsida, Hans Lennernäs, Femke Heindryckx

    Published 2022-02-01
    “…Hepatocellular carcinoma (HCC) is one of the most common and deadly cancers worldwide. …”
    Get full text
    Article
  7. 307

    Up-to-date Knowledge on the Pathological Diagnosis of Hepatocellular Carcinoma by Ji Hae Nahm, Young Nyun Park

    Published 2021-11-01
    “…Hepatocellular carcinoma (HCC) has heterogeneous molecular and pathological features and biological behavior. …”
    Get full text
    Article
  8. 308
  9. 309
  10. 310
  11. 311

    Radiation therapy in the era of immune treatment for hepatocellular carcinoma by Lingjuan Chen, Ruiguang Zhang, Zhenyu Lin, Qiaoyun Tan, Zhiyong Huang, Binyong Liang

    Published 2023-01-01
    “…Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment in recent years and provide new opportunities to treat hepatocellular carcinoma (HCC). To date, several ICIs have been approved by the FDA for advanced HCC in first-line or second-line therapy. …”
    Get full text
    Article
  12. 312
  13. 313
  14. 314

    Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis by Patrick Marquardt, Po‐Hong Liu, Joshua Immergluck, Jocelyn Olivares, Ana Arroyo, Nicole E. Rich, Neehar D. Parikh, Adam C. Yopp, Amit G. Singal

    Published 2021-09-01
    “…Professional society guidelines recommend semiannual screening for hepatocellular carcinoma (HCC) in patients with cirrhosis; however, studies suggest underuse of screening in clinical practice. …”
    Get full text
    Article
  15. 315
  16. 316
  17. 317
  18. 318
  19. 319
  20. 320

    A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma by Yu Rim Lee

    Published 2023-09-01
    “…Hepatocellular carcinoma (HCC) is a highly aggressive disease that is usually diagnosed at an advanced stage. …”
    Get full text
    Article